LensAR Receives $10M Debt Facility from Oxford Finance

LensAR, an Orlando medical device company commercializing laser and 3D imaging technology for refractive cataract surgery, has has received a $10M debt facility from Oxford Finance LLC.  LensAR intends to use the funding for the commercialization of its LensAR Laser System, which recently received FDA clearance. Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies. ”Oxford is impressed with the LensAR™ Laser System, and even prior to the FDA’s clearance, the market demand for the product was quite promising,” said Christopher A. Herr, managing director for Oxford Finance. ”Now that LensAR has received the 510K clearance on our commercial laser system, we are moving very quickly into the commercial launch stage,” said Nick Curtis, CEO of LensAR.  Read more here.